These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 25483366

  • 1. Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
    Catalano A, Morabito N, Basile G, Cucinotta D, Lasco A.
    Eur J Clin Invest; 2015 Feb; 45(2):144-9. PubMed ID: 25483366
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships.
    Kane L, Moore K, Lütjohann D, Bikle D, Schwartz JB.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4400-9. PubMed ID: 24030939
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.
    Chen ZG, Cai HJ, Jin X, Lu JH, Wang J, Fang NY.
    Arch Gerontol Geriatr; 2014 Nov; 59(3):515-21. PubMed ID: 25131773
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal.
    Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L.
    BMC Musculoskelet Disord; 2018 Jul 03; 19(1):210. PubMed ID: 29970059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is calcifediol better than cholecalciferol for vitamin D supplementation?
    Quesada-Gomez JM, Bouillon R.
    Osteoporos Int; 2018 Aug 03; 29(8):1697-1711. PubMed ID: 29713796
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
    Barros X, Rodríguez NY, Fuster D, Rodas L, Esforzado N, Mazza A, Rubello D, Campos F, Tapias A, Torregrosa JV.
    J Nephrol; 2016 Oct 03; 29(5):703-9. PubMed ID: 26454858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators.
    Clin Ther; 2009 Dec 03; 31(12):2824-38. PubMed ID: 20110022
    [Abstract] [Full Text] [Related]

  • 15. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ, Aiedeh KM, Hadidi KA.
    Ann Saudi Med; 2015 Dec 03; 35(1):13-8. PubMed ID: 26142932
    [Abstract] [Full Text] [Related]

  • 16. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity.
    Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, Sidelnikov E, Willett WC, Edel JO, Stähelin HB, Wolfram S, Jetter A, Schwager J, Henschkowski J, von Eckardstein A, Egli A.
    J Bone Miner Res; 2012 Jan 03; 27(1):160-9. PubMed ID: 22028071
    [Abstract] [Full Text] [Related]

  • 17. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM, Theobald HE, Sanders TA.
    J Nutr; 2012 Jul 03; 142(7):1286-90. PubMed ID: 22623396
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
    Tanriverdi HA, Barut A, Sarikaya S.
    Eur J Obstet Gynecol Reprod Biol; 2005 May 01; 120(1):63-8. PubMed ID: 15866088
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial.
    Pérez-Castrillón JL, Dueñas-Laita A, Gómez-Alonso C, Jódar E, Del Pino-Montes J, Brandi ML, Cereto Castro F, Quesada-Gómez JM, Gallego López L, Olmos Martínez JM, Alhambra Expósito MR, Galarraga B, González-Macías J, Neyro JL, Bouillon R, Hernández-Herrero G, Fernández-Hernando N, Chinchilla SP.
    J Bone Miner Res; 2023 Apr 01; 38(4):471-479. PubMed ID: 36661855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.